Related Experiment Videos
A polymorphism in intron 2 of the TP53 gene
1Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 142631, USA.
Clinical Genetics
|August 1, 1996
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.
British journal of cancer·2009
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.
British journal of cancer·2009
The 21st century role of Piver type II hysterectomy in FIGO stage IA, IB cervical cancer: a personal perspective.
European journal of gynaecological oncology·2008
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
British journal of cancer·2004
Assessment of family cancer history collection and utilization in patient care.
Community genetics·2004
A ten-year remission maintained by 6,272 mg (3,920 mg/m2) cumulative dose of cisplatin-based chemotherapy for recurrent epithelial ovarian cancer.
European journal of gynaecological oncology·2002
Epigenetic-proteomic network crosstalk at birth across HLA risk groups in type 1 diabetes.
Frontiers in immunology·2026
ADAMTS18 as a candidate gene linking social stress and depression: a cross-species study in African wild dogs (Lycaon pictus) and humans.
Frontiers in behavioral neuroscience·2026